Skip to contentSkip to filters

We use cookies for analytics.

Seminar, Hosted by Xtalks

Use PET and MRI Imaging Methods Early to Reduce Drug Development Risk

Eugenii A. (Ilan) Rabiner, BSc (Hons), MBBCh, FCPsych SA

Perceptive Discovery

Abstract

PET and MRI can answer different questions before expensive late-stage drug trials begin. The speaker examines measurement of tissue exposure, target occupancy and pharmacodynamic response, and how early imaging can inform dose selection and decisions about further development.

Topics